Simply Good Foods Co financial statements

Income statement, balance sheet and cash flow statement for the last 9 fiscal years, taken from the XBRL data Simply Good Foods Co files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue		438	524	817	1,006	1,169	1,243	1,331	1,451
Cost of revenue		255	306	492	596	723	789	820	925
Gross profit		183	218	324	410	446	453	512	526
Research and development		2.5	2.2	4	3.5	4.1	4.3	5.4	5.5
Selling and marketing		59.2	67.7	94.5	113	122	119	144	134
General and administrative		49.4	62.2	106	106	104	112	130	156
Operating expenses		116	145	246	236	243	248	305	369
Operating income		67.4	72.7	78.2	174	203	205	206	157
Interest expense		12.6	13.6	32.8	31.6	21.9	30.1	26	23.2
Interest income		0	3.83	1.52	0.08	0.02	1.14	4.31	2.66
Other non-operating income		-46	-81.2	0.74	-92.8	-52.2	-29.3	-20.4	-21
Pre-tax income		21.3	-8.52	79	80.9	151	176	186	136
Income tax		-16.1	16.7	13.3	40	42	42.1	46.7	32.3
Net income	10	37.4	-25.2	65.6	40.9	109	134	139	104
EBITDA		75	80.3	94.2	192	222	225	227	178
EPS, basic		0.53	-0.31	0.70	0.43	1.10	1.34	1.39	1.03
EPS, diluted		0.51	-0.31	0.35	0.42	1.08	1.32	1.38	1.02
Shares, basic (weighted)		70.6	80.7	94	95.7	98.8	99.4	99.9	101
Shares, diluted (weighted)		72.8	80.7	98.3	97.4	101	101	101	102

Balance sheet

	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Cash and equivalents	78.5	112	266	95.8	75.3	67.5	87.7	133	98.5
Receivables	42.8	36.6	44.2	89.7	111	133	145	151	165
Inventory	27.5	30	38.1	59.1	97.3	125	117	142	167
Other current assets	8.35	5.08	6.06	11.9	9.69	20.9	16	9.19	15.8
Total current assets	159	186	358	260	299	352	372	440	454
Property, plant and equipment	2.27	2.57	2.46	11.9	16.6	18.2	24.9	24.8	39.7
Lease right-of-use assets				25.7	46.2	46.5	40	35.1	44.1
Goodwill	40.7	471	471	545	543	543	543	592	590
Intangible assets	186	313	306	1,159	1,139	1,123	1,108	1,336	1,262
Other non-current assets	1.85	2.23	4.02	32.8	54.8	58.1	49.3	42.9	51
Total assets	390	975	1,142	2,008	2,052	2,094	2,097	2,436	2,396
Accounts payable	18.8	11.2	15.7	32.2	59.7	62.1	52.7	58.6	78.3
Accrued liabilities				38	53.6	39.7	35.1	49.8	46.2
Short-term debt	11.4	0.65	0.68	0.27	0.29	0.26	0.14	0
Total current liabilities	50.8	30.6	48	71.5	114	102	89.9	109	125
Long-term debt	322	191	190	597	451	403	282	397	249
Lease liabilities				22.8	44.9	44.5	37.3	34.3	49.5
Other non-current liabilities		0.86	0.53	22.8	44.9	44.6	38.3	36.5	49.5
Total liabilities	417	302	429	869	863	656	526	709	589
Total debt	333	192	191	597	452	403	282	397	249
Paid-in capital	-43.6	596	716	1,076	1,085	1,287	1,303	1,320	1,347
Retained earnings	16.2	24.5	-0.71	64.9	106	214	348	487	591
Treasury stock		0	-2.15	-2.15	-2.15	-62	-78.5	-78.5	-129
Other comprehensive income	-0.44	-0.8	-0.84	-0.88	-0.82	-1.95	-2.59	-2.04	-2.43
Shareholders' equity	-27.8	621	713	1,139	1,189	1,439	1,571	1,727	1,807
Total equity	-27.8	621	713	1,139	1,189	1,439	1,571	1,727	1,807
Total liabilities and equity	390	975	1,142	2,008	2,052	2,094	2,097	2,436	2,396
Shares outstanding		70.6	81.9	95.7	95.8	99.5	99.6	100	99.7

Cash flow statement

	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Net income	10	37.4	-25.2	65.6	40.9	109	134	139	104
Depreciation and amortization	1.1	7.67	7.64	16	18.2	19.3	20.3	21	21.4
Stock-based compensation		4.03	5.5	7.64	8.27	11.7	14.5	18.4	15.3
Deferred income tax		-20.3	10.9	8.22	9.4	11.8	10.6	8.37	0
Change in receivables		-6.16	-8.36	-18.3	-22.3	-21.8	-13.4	9.13	-14.7
Change in inventory		2.43	-8.18	23.9	-39.3	-29.5	8.17	13.7	-25.8
Change in payables		-3.6	4.73	-8.74	25.9	2.88	-9.51	-15.5	18.5
Cash from operations		61	73	58.9	132	111	171	216	178
Capital expenditures		-1.77	-1.04	-1.74	-5.91	-5.23	-11.6	-5.74	-20.5
Acquisitions						0	0	280	1.71
Cash from investing		-3.51	-1.79	-984	-2.51	-8.16	-12.2	-287	-20.9
Debt issued		0	0	460	0	0	0	250	0
Debt repaid		-1.5	-2	-50	-150	-50	-122	-135	-150
Stock issued		0	0	353	0	0	5.25	4.29	12.9
Share buybacks		0	-2.15	0	0	-59.9	-16.4	0	-50.9
Cash from financing		-1.59	83.4	755	-150	-110	-139	116	-191
Exchange rate effect		-0.47	-0.26	-0.07	-0.04	-0.3	-0.18	0.09	-0.38
Net change in cash				-170	-20.5	-7.55	20.4	44.7	-33.7
Free cash flow		59.3	72	57.2	126	105	160	210	158
Interest paid		11.2	11.2	30	27.8	19.2	25.5	25.7	22
Income taxes paid		4.58	7.45	4.53	32.2	49.2	27.4	33.2	39.3

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to May 30, 2026; growth uses fiscal years. Valuation uses the share price of $9.60 on September 25, 2026.

Profitability

Metric	Value	How it is calculated
Gross margin	32.7%	Gross profit / revenue.
Operating margin	-17.1%	Operating income / revenue.
EBITDA margin	-15.6%	EBITDA (operating income + depreciation and amortization) / revenue.
Net margin	-14.3%	Net income / revenue.
FCF margin	8.6%	Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin	10.6%	Cash from operations / revenue.
Return on equity (ROE)	-14.0%	Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)	-9.6%	Net income / average total assets.
Return on invested capital (ROIC)	-11.1%	Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
Stock-based pay / revenue	1.1%	Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue	2.0%	Capital expenditures / revenue.
D&A / revenue	1.5%	Depreciation and amortization / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	9.0%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	7.5%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y	12.2%	Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y	2.8%	Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y	5.7%	Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y	10.1%	Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y	-24.0%	Operating income vs the same period a year earlier. Only from a positive base.
Operating income CAGR, 3y	-8.2%	Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating income CAGR, 5y	14.9%	Compound annual growth of operating income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EBITDA growth, 1y	-21.6%	EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y	-7.1%	Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA CAGR, 5y	13.6%	Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Net income growth, 1y	-25.6%	Net income vs the same period a year earlier. Only from a positive base.
Net income CAGR, 3y	-1.5%	Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Net income CAGR, 5y	9.6%	Compound annual growth of net income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EPS growth, 1y	-26.1%	EPS vs the same period a year earlier. Only from a positive base.
EPS CAGR, 3y	-1.9%	Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EPS CAGR, 5y	23.9%	Compound annual growth of eps over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow growth, 1y	-17.3%	Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y	17.3%	Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y	24.8%	Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow growth, 1y	-24.8%	Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 3y	14.4%	Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Free cash flow CAGR, 5y	22.5%	Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y	4.6%	Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y	7.9%	Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y	9.7%	Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y	-1.6%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	4.6%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y	3.6%	Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y	0.2%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	0.3%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y	0.6%	Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	4.80x	Current assets / current liabilities.
Quick ratio	2.89x	(Cash + short-term investments + receivables) / current liabilities.
Cash ratio	1.28x	(Cash + short-term investments) / current liabilities.
Debt / equity	0.28x	Total debt / shareholders' equity. Not shown when equity is negative.
Debt / assets	19.3%	Total debt / total assets.
Liabilities / assets	31.2%	Total liabilities / total assets.
Net debt	$273.2M	Total debt - cash - short-term investments. Negative means more cash than debt.
Interest coverage	-11.8x	Operating income / interest expense.
Working capital	$367.4M	Current assets - current liabilities.
Goodwill and intangibles / assets	73.2%	(Goodwill + intangible assets) / total assets.
Tangible book value	-$90.7M	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	0.68x	Revenue / average total assets.
Fixed asset turnover	32.9x	Revenue / average property, plant and equipment.
Receivables turnover	8.92x	Revenue / average receivables.
Days sales outstanding	41 days	365 x average receivables / revenue.
Capex / operating cash flow	19.1%	Capital expenditures / cash from operations, when that is positive.

Per share

Metric	Value	How it is calculated
EPS, diluted	-$2.21	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share	$15.48	Revenue / diluted weighted shares.
FCF per share	$1.33	Free cash flow / diluted weighted shares.
Operating cash flow per share	$1.64	Cash from operations / diluted weighted shares.
Book value per share	$15.77	Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share	-$1.01	Tangible book value / shares outstanding.
Cash per share	$1.38	(Cash + short-term investments) / shares outstanding.
Buybacks / FCF	200.8%	Share buybacks / free cash flow, when free cash flow is positive.

Valuation

Metric	Value	How it is calculated
Market cap	$849.2M	Share price x shares outstanding.
Enterprise value	$1.12B	Market cap + total debt - cash - short-term investments.
P/S	0.61x	Market cap / revenue.
P/B	0.60x	Market cap / shareholders' equity. Only when equity is positive.
P/FCF	7.11x	Market cap / free cash flow. Only when free cash flow is positive.
P/OCF	5.76x	Market cap / cash from operations, when positive.
EV/Sales	0.81x	Enterprise value / revenue.
EV/FCF	9.40x	Enterprise value / free cash flow, when both are positive.
FCF yield	14.1%	Free cash flow / market cap.
Earnings yield	-23.4%	Net income / market cap (the inverse of P/E).
Shareholder yield	28.2%	(Dividends paid + share buybacks) / market cap.

What was Simply Good Foods Co's revenue in fiscal 2025?

Simply Good Foods Co reported revenue of $1.45B for fiscal 2025, 9% higher than the year before.

Was Simply Good Foods Co profitable in fiscal 2025?

Yes. Net income was $103.6M, a net margin of 7.1%.

How much free cash flow did Simply Good Foods Co generate in fiscal 2025?

Cash from operations of $178.5M minus capital expenditures of $20.5M left free cash flow of $157.9M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to Simply Good Foods Co